***Abstract submission deadline extended to 7th August 2023***
Dear Prof. / Assoc. Prof. / Dr / Sir / Madam,
Greetings!
On behalf of the Malaysian Association for Cancer Research (https://macr-cancer.org/), we would like to extend our warmest invitation to you to participate in the International Conference on Drug Discovery and Translational Medicine 2023 (ICDDTM'23), scheduled to take place on 5th and 6th December 2023 at the Unicorn Hotel, Sri Kembangan, Selangor. With the conference theme “Scientific Discoveries: Impacting Healthcare and Driving Economic Growth”, ICDDTM’23 is geared to examine the symbiotic relationship between science and economy; and bring to the fore the crucial role of scientific innovations in advancing a nation's economy.
On 4th and 8th of December 2023, we will also be hosting pre-conference workshops and post-conference symposiums. Please stay tuned for more updates from us. The in-person conference will feature plenary and invited talks, and oral and poster presentations focusing on the following research areas:
- Cancer
- Infectious Diseases
- Inflammatory and Metabolic Diseases
- Mental Health / Neurodegeneration
- Miscellaneous (Cardiovascular Pharmacology / Drug Design / Delivery / Pharmacoeconomics)
So far, we have confirmed the following line-up of plenary and invited speakers:
- Prof. Dr Godefridus J. (Frits) Peters, Amsterdam University Medical Centers, The Netherlands
- Prof. Dr Sanjeev Krishna, St George’s University of London, United Kingdom
- Prof. Dr Brian Blagg, University of Notre Dame, United States
- Prof. Dr Marek C. Chawarski, Yale University, United States
- Prof. Dr Habibah A. Wahab, Universiti Sains Malaysia, Malaysia
- Prof. Dr Fred Wong Wai-Shiu, National University of Singapore, Singapore
- Prof. Dr Asrul Akmal Shafie, Universiti Sains Malaysia, Malaysia
- Prof. Dr Balram Chowbay, National University of Singapore, Singapore
- Dr Yolanda Augustin, St George’s University of London, United Kingdom
- Dr Voon Pei Jye, Sarawak General Hospital, Malaysia
The conference programme also includes two forums on:
- The use of ketum for medical purposes
- Stem cell industry
And five pre-conference workshops:
- GraphPad Prism
- Molecular Pharming
- Pharmacometrics
- Cancer Drug Discovery
- AI in Drug Design and Discovery
And two post-conference symposiums:
- Gel-Based Proteomics and Biochemical Pathway Mapping via Ingenuity Pathway Analysis (IPA)
- Behavioural Neuroscience: A Practical Approach to the Study of Psychoactive Drugs
We will also launch the International Affordable Diagnostics and Therapeutics Alliance (IADATA). The initiative aims to improve access to drug treatments for low-income patients. The Malaysian Association for Cancer Research will be the main driver of the initiative and collaborate with academic institutions in the United Kingdom and Singapore.
More details will be published on our website soon!
MMA, MPS, and MMC CPD points will be awarded. Attractive prizes will be awarded to best oral and poster presenters.
Travel awards will be given to students and early-career researchers who meet our selection criteria. For more information, please check out our website (https://icddtm23.macr-cancer.org/). Stay tuned for regular updates!
Registration is open now, but hurry up as seats are limited! Abstract submission will be closed on 7th August 2023 (originally 7th July), whereas early-bird registration will be closed on 1st September 2023. For more information about the conference program and how to participate, please take a look at the enclosed flyer or visit our website (https://icddtm23.macr-cancer.org/).
Thank you.
Yours sincerely,
--
Dr Chua Eng Wee,
Lecturer
Faculty of Pharmacy
Universiti Kebangsaan Malaysia
- Secretary of ICDDTM'23 Organising Committee
0 comments